Variability of Insulin Requirements in Adults with Type 2 Diabetes During Fully Closed-Loop Insulin Delivery
Diabetes Technology & Therapeutics · 2023
DOI: 10.1089/dia.2023.0073 ↗Kurz gefasst
Leserbrief in der Zeitschrift Diabetes Technology & Therapeutics, 2023. Verfasst von Rama Lakshman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom.
- Wolfson Diabetes and Endocrine Clinic, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
ORCID-Profile: Rama Lakshman, Charlotte K Boughton
Zitieren
APA
Lakshman, R., Daly, A. B., Nwokolo, M., Hartnell, S., Wilinska, M. E., Cezar, A., Evans, M. L., Hovorka, R., & Boughton, C. K. (2023). Variability of Insulin Requirements in Adults with Type 2 Diabetes During Fully Closed-Loop Insulin Delivery. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2023.0073
Vancouver
Lakshman R, Daly AB, Nwokolo M, Hartnell S, Wilinska ME, Cezar A, et al. Variability of Insulin Requirements in Adults with Type 2 Diabetes During Fully Closed-Loop Insulin Delivery. Diabetes Technology & Therapeutics. 2023. doi:10.1089/dia.2023.0073
BibTeX
@article{Lakshman2023,
author = {Lakshman, Rama and Daly, Aideen B and Nwokolo, Munachiso and Hartnell, Sara and Wilinska, Malgorzata E and Cezar, Alina and Evans, Mark L and Hovorka, Roman and Boughton, Charlotte K},
title = {Variability of Insulin Requirements in Adults with Type 2 Diabetes During Fully Closed-Loop Insulin Delivery},
journal = {Diabetes Technology & Therapeutics},
year = {2023},
doi = {10.1089/dia.2023.0073}
}
EUVIMED